Authors
Latest:
DAURISMO for Acute Myeloid LeukemiaOn November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
Latest:
Old Drugs Are New AgainUnique formulations, new indications, and the 'rediscovery' of already approved drugs are just a few of the innovations pharmacists can expect as drug makers revitalize their product portfolios.
Latest:
PREP Act Provides Opportunities for Advanced RolesCan the profession afford not to retain expanded job roles for technicians in a post-pandemic era?
Latest:
Focus on the Medical Benefit: A Manufacturer's PerspectiveAs more specialty pharmaceuticals products continue to come to the market, the manufacturer's goal should be to understand what will impact payer coverage.
Latest:
EntrestoEntresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.
Latest:
The Application of Drug-Dosing Guidelines Based on Preemptive Genetic TestingThe application of genetic data to effectively influence health care outcomes is poised for rapid acceptance. Genetic testing can provide results that can be used to make the best therapeutic choices.
Latest:
How Pharmacists Can Help Patients Save MoneyMedication is not cheap, but we can help ensure that cost is not a barrier to adherence. Here are some tips.
Latest:
McCurdy Advances the Profession of Pharmacy Through Strong Community SpiritThis month's RESPy winner, UCSF School of Pharmacy's Megan McCurdy, is a true champion of community volunteerism and advancing the pharmacy profession.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
Latest:
Bispecific Antibodies: The Next Generation of ImmunotherapyAdvances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Latest:
Rare Pharmacy Emerges From Specialty, Part 2Challenges and impact of rare diseases are faced by pharmacy stakeholders.
Latest:
Initiating an Antimicrobial Stewardship Program: The Costs and the BenefitsFor decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
The Impending Patent Cliff: Implications for PharmacistsAs blockbuster drugs begin losing patent protection, pharmaceutical companies and pharmacists will address key marketplace changes.
Latest:
Specialty Pharmacy: Making a DifferenceWe welcome our new editorial advisory board member, a leader and innovator in the industry.
Latest:
Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionPharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Latest:
Pharmacist In Action: Pandemic Delivers Student a Unique RotationBen Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.
Latest:
Hypertension: Revealing the Silent KillerHypertension is a leading modifiable risk factor for heart disease and stroke.
Latest:
Generic Drug Trends-What's Next?Big changes are coming in the generic marketplace worldwide in the coming decade.
Latest:
Case Studies (January 2020)What could be causing this patient's involuntary, repetitive movements in her arms and legs?
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
